Thermo Fisher Scientific (TMO) Other Operating Expenses (2009 - 2026)

Thermo Fisher Scientific has reported Other Operating Expenses for 18 years, with the latest figure at $7.1 billion in Q2 2026.

• Other Operating Expenses for Q2 2026 came in at $7.1 billion, up 10.31% year-over-year; the trailing twelve-month figure through Jun 2026 was $27.4 billion (up 7.91% YoY), and the FY2025 annual result was $26.3 billion, up 4.53% from the prior year.
• Other Operating Expenses climbed to $7.1 billion in Q2 2026, from $6.6 billion in the prior quarter.
• Over five years, Other Operating Expenses peaked at $7.2 billion in Q4 2025 and troughed at $6.1 billion in Q1 2025.
• A 5-year average of $6.5 billion and a median of $6.4 billion in 2023 frame the typical range for Other Operating Expenses.
• The widest annual swing landed in 2022, when Other Operating Expenses jumped 36.25%; it then declined 6.56% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $6.8 billion in 2022, then fell by 5.13% to $6.5 billion in 2023, then gained by 1.25% to $6.6 billion in 2024, then gained by 9.61% to $7.2 billion in 2025, then fell by 1.3% to $7.1 billion in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $7.1 billion in Q2 2026, $6.6 billion in Q1 2026, and $7.2 billion in Q4 2025.